CN Stock MarketDetailed Quotes

688105 Nanjing Vazyme Biotech

Watchlist
  • 18.82
  • -0.26-1.36%
Post Market Sep 10 15:00 CST
7.53BMarket Cap285.15P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing Vazyme Biotech Q2 2024 Earnings Date

Currency：CNYAug 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
347.70M
--
+29.33%
Net Income
--
10.43M
--
+133.88%
Analyst Rating
Strong Buy

Sep 10, 2024

Nanjing Vazyme Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--
--------
--------
--------

Unlock Free Earnings Estimates

Nanjing Vazyme Biotech Earnings Reports

  • 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Voluntary disclosure announcement of Noritz's 2024 interim performance forecast.

    Jul 9 12:00 ET

  • 2024 First Quarter Report

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg